Clinical trial
Effect of a Blink Reminder Program on the Progression of Meibomian Gland Loss in Intensive Digital Screen Users: a Randomized Controlled Trial With Infrared Meibography
NCT07430137 is registered in ClinicalTrials.gov with Asociación para Evitar la Ceguera en México as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of a Blink Reminder Program on the Progression of Meibomian Gland Loss in Intensive Digital Screen Users: a Randomized Controlled Trial With Infrared Meibography
- Lead sponsor
- Asociación para Evitar la Ceguera en México
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 19, 2026
- Completion date
- August 31, 2026
- Enrollment
- 28 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye syndromes, meibomian gland dysfunction (disorder)